Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 10, 2020

SELL
$24.84 - $45.46 $200,980 - $367,816
-8,091 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$22.78 - $29.08 $146,612 - $187,158
-6,436 Reduced 44.3%
8,091 $201,000
Q2 2019

Aug 07, 2019

SELL
$15.0 - $22.49 $191,250 - $286,747
-12,750 Reduced 46.74%
14,527 $320,000
Q1 2019

May 13, 2019

BUY
$14.02 - $16.74 $178,755 - $213,434
12,750 Added 87.77%
27,277 $441,000
Q3 2018

Nov 08, 2018

BUY
$12.21 - $16.61 $177,374 - $241,293
14,527 New
14,527 $228,000

Others Institutions Holding ZYME

About Zymeworks Inc.


  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $920M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.